Login / Signup

Lung clearance index (LCI 2.5 ) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.

Donald S UrquhartHeather DowleKellie MoffatJody ForsterSteve CunninghamKenneth A Macleod
Published in: Pediatric pulmonology (2024)
values being recorded in the real world of children with CF.
Keyphrases
  • cystic fibrosis
  • young adults
  • study protocol
  • randomized controlled trial
  • big data
  • machine learning